The vascular and cardioprotective effects of liriodenine in ischemia-reperfusion injury via NO-dependent pathway

Nitric Oxide - Biology and Chemistry

Volumn 11, Issue 4, 2004, Pages 307-315

  Chang, Wei Luen ^a   Chung, Ching Hu ^a   Wu, Yang Chang ^b   Su, Ming Jai ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

eNOS; HUVEC; Ischemia reperfusion heart; Liriodenine; Nitric oxide; Quinidine

Indexed keywords

LIRIODENINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL BLOCKING AGENT; QUINIDINE; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL MODEL; APOPTOSIS; ARTERY OCCLUSION; ARTICLE; CARDIOVASCULAR DISEASE; CELL CULTURE; CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENDOTHELIUM CELL; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HUMAN CELL; ISCHEMIA; ISOLATED HEART; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; APORPHINES; CARDIOTONIC AGENTS; CORONARY CIRCULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MALE; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; QUINIDINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

FISSISTIGMA;

EID: 10344254299     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2004.10.004     Document Type: Article

References (39)

1. D.J. Hearse, and R. Bolli Reperfusion induced injury: manifestations, mechanisms, and clinical relevance Cardiovasc. Res. 26 1992 101 108
2. E. Braunwald, and R.A. Kloner Myocardial reperfusion: a double-edged sword? J. Clin. Invest. 76 1985 713 719
3. T.M. Scarabelli, R.A. Knight, N.B. Rayment, T.J. Cooper, A. Stephanou, B.K. Brar, K.M. Lawrence, G. Santilli, D.S. Latchman, G.F. Baxter, and D.M. Yellon Quantitative assessment of cardiac myocyte apoptosis in tissue sections using the fluorescence-based tunel technique enhanced with counterstains J. Immunol. Methods 228 1999 23 28
4. N. Kaeffer, V. Richard, A. Francois, F. Lallemand, J.P. Henry, and C. Thuillez Preconditioning prevents chronic reperfusion-induced coronary endothelial dysfunction in rats Am. J. Physiol. 271 1996 H842 H849
5. D.D. ku Coronary vascular reactively after acute myocardial ischemia Science 218 1982 576 578
6. K.M. Van Benthuysen, I.F. McMurtry, and L.D. Horwitz Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro J. Clin. Invest. 79 1987 265 274
7. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
8. L.J. Ignarro, H. Lippton, J.C. Edwards, W.H. Baricos, A.L. Hyman, P.J. Kadowtiz, and C.A. Gruetter Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates J. Pharmacol. Exp. Ther. 218 1981 739 749
9. L.J. Ignarro, C. Napoli, and J. Loscalzo Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview Circ. Res. 90 2002 21 28
10. B.T. Mellion, L.J. Ignarro, E.H. Ohlstein, E.G. Pontecorovo, A.L. Hyman, and P.J. Kadowitz Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators Blood 57 1981 946 955
11. P. Kubes, and D.N Granger Nitric oxide: an endogenous modulator of leukocyte adhesion Proc. Natl. Acad. Sci. USA 88 1991 4651 4655
12. K. Laude, C. Thuillez, and V. Richard Coronary endothelial dysfunction after ischemia and reperfusion: a new therapeutic target? Braz. J. Med. Biol. Res. 34 2001 1 7
13. S.T. Lu, Y.C. Wu, and S.P. Leou Alkaloid of Fissistigma glaucescens and Goniothalamas species Phytochemistry 24 1985 1829 1834
14. S. Chulia, M.A. Noguera, M.D. Ivorra, D. Cortes, and M.P. D'Ocon Vasodilator effects of liriodenine and norushinsunine, two aporphine alkaloids isolated from Annona cherimolia, in rat aorta Pharmacology 50 1995 380 387
15. C.H. Lin, G.J. Chang, M.J. Su, Y.C. Wu, C.M. Teng, and F.N. Ko Pharmacological characteristics of liriodenine, isolated from Fissistigma glaucescens, a novel muscarinic receptor antagonist in guinea-pigs Br. J. Pharmacol. 113 1994 275 281
16. G..J. Chang, M.H. Wu, Y.C. Wu, and M.J. Su Electrophysiological mechanisms for antiarrhythmic efficacy and positive inotropy of liriodenine, a natural aporphine alkaloid from Fissistigma glaucescens Br. J. Pharmacol. 118 1996 1571 1583
17. W.L. Chang, Y.C. Wu, M.J. Su, Ischemia and/or reperfusion-induced arrhythmia in anesthetized rats: prevention by liriodenine, in: Third International Congress on Coronary Artery Disease from Prevention to Intervention, 2000, Abstract 23
18. E.A. Jaffe, R.L. Nachman, C.G. Becker, and C.R. Minick Culture of human endothelial cells derived from umbilical veins J. Clin. Invest. 52 1973 2745 2756
19. O. Huet, J.M. Petit, M.H. Ratinaud, and R. Julien NADH-dependent dehydrogenase activity estimation by flow cytometric analysis of 3-(4,5-dimethylthiazolyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction Cytometry 13 1992 532 539
20. M.J. Curtis, and D.J. Hearse Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation J. Mol. Cell. Cardiol. 21 1989 21 40
21. D.C. Warltier, M.G. Zyvoloski, G.J. Gross, H.F. Hardman, and H.L. Brooks Determination of experimental myocardial infarct size J. Pharmacol. Methods 6 1981 199 210
22. R.R. Giraldez, A. Panda, Y. Xia, S.P. Sanders, and J.L. Zweier Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart J. Biol. Chem. 272 1997 21420 21426
23. F. Yang, E. Troncy, M. Francoeur, B. Vinet, P. Vinay, G. Czaika, and G. Blaise Effects of reducing reagents and temperature on conversion of nitrite and nitrate to nitric oxide and detection by chemiluminescence Clin. Chem. 43 1997 657 662
24. S. Takeo, K. Tanonaka, K. Shimizu, K. Hirai, K. Miyake, and R. Minematsu Beneficial effects of lidocaine and disopyramide on oxygen-deficiency-induced contractile failure and metabolic disturbance in isolated rabbit hearts J. Pharmacol. Exp. Ther. 248 1989 306 314
25. J.X. Liu, K. Tanonaka, A. Sanbe, K. Yamamoto, and S. Takeo Beneficial effects of quinidine on post-ischemic contractile failure of isolated rat hearts J. Mol. Cell. Cardiol. 25 1993 1249 1263
26. M.J. Su, Y.C. Nieh, H.W. Huang, and C.C. Chen Dicentrine, an alpha-adrenoceptor antagonist with sodium and potassium channel blocking activities Naunyn. Schmiedebergs. Arch. Pharmacol. 349 1994 42 49
27. Y. Maejima, S. Adachi, H. Ito, K. Nobori, M. Tamamori-Adachi, and M. Isobe Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity Cardiovasc. Res. 59 2003 308 320
28. C.L. Wainwright, A.M. Miller, L.M. Work, and P. Del Soldato NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs Br. J. Pharmacol. 135 2002 1882 1888
29. J. Pernow, Y. Uriuda, Q.D. Wang, X.S. Li, R. Nordlander, and L. Rydén The protective effect of l-arginine on myocardial injury and endothelial function following ischemia and reperfusion in the pig Eur. Heart J. 15 1994 1712 1719
30. R. Pabla, A.J. Buda, D.M. Flynn, D.B. Salzberg, and D.J. Lefer Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function Am. J. Physiol. 269 1995 H1113 H1121
31. M. Kitakaze, K. Node, T. Minamino, H. Kosaka, Y. Shinozaki, H. Mori, M. Inoue, M. Hori, and T. Kamada Role of nitric oxide in regulation of coronary blood flow during myocardial ischemia in dogs J. Am. Coll. Cardiol. 27 1996 1804 1812
32. V. Richard, K. Laude, C. Artigues, N. Kaeffer, J.P. Henry, and C. Thuillez Heat stress increases endothelium-dependent relaxations and prevents reperfusion-induced endothelial dysfunction Clin. Exp. Pharmacol. Physiol. 2002 956 962
33. J. Haendeler, U. Weiland, A.M. Zeiher, and S. Dimmeler Effects of redox-related congeners of NO on apoptosis and caspase-3 activity Nitric Oxide 1 1997 282 293
34. S. Dimmeler, J. Haendeler, M. Nehls, and A.M. Zeiher Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases J. Exp. Med. 185 1997 601 608
35. L. Rossig, J. Haendeler, C. Hermann, P. Malchow, C. Urbich, A.M. Zeiher, and S. Dimmeler Nitric oxide down-regulates MKP-3 mRNA levels. Involvement in endothelial cell protection from apoptosis J. Biol. Chem. 275 2000 25502 25507
36. C. Hermann, and A.M. Zeiher Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase Arterioscler. Thromb. Vasc. Biol. 17 1997 3588 3592
37. J.M. McCord Oxygen-derived free radicals in postischemic tissue injury N. Engl. J. Med. 312 1985 159 163
38. H. Wang, L. Lin, J. Jiang, Y. Wang, Z.Y. Lu, J.A. Bradbury, F.B. Lih, D.W. Wang, and D.C. Zeldin Upregulation of endothelial nitric oxide synthase by endothelium-derived hyperpolarizing factor involves MAPK and PKC signaling pathways J. Pharmacol. Exp. Ther. 307 2003 753 764
39. H. Li, C. Burkhardt, U.R. Heinrich, I. Brausch, N. Xia, and U. Forstermann Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells Circulation 107 2003 2348 2354